🇺🇸 FDA

Drug profile · INN

pertuzumab, trastuzumab, and hyaluronidase-zzxf

PHESGO

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

pertuzumab, trastuzumab, and hyaluronidase-zzxf (PHESGO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

Key facts

INN pertuzumab, trastuzumab, and hyaluronidase-zzxf
Brand PHESGO
Route SUBCUTANEOUS
Formulation INJECTABLE

Frequently asked questions

What is pertuzumab, trastuzumab, and hyaluronidase-zzxf?

pertuzumab, trastuzumab, and hyaluronidase-zzxf (PHESGO) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

What is the brand name for pertuzumab, trastuzumab, and hyaluronidase-zzxf?

PHESGO is a marketed brand name for pertuzumab, trastuzumab, and hyaluronidase-zzxf. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pertuzumab, trastuzumab, and hyaluronidase-zzxf?

pertuzumab, trastuzumab, and hyaluronidase-zzxf has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.